193 related articles for article (PubMed ID: 34153502)
1. Allogenic Hematopoietic Stem Cell Transplantation Is Feasible in Pediatric Patients with an Active or Recently Diagnosed Invasive Fungal Infection.
Rotte LGY; Loeffen YGT; Bierings MB; Wolfs TFW; Lindemans CA
Transplant Cell Ther; 2021 Sep; 27(9):781.e1-781.e5. PubMed ID: 34153502
[TBL] [Abstract][Full Text] [Related]
2. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
3. Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina.
Gomez SM; Caniza M; Fynn A; Vescina C; Ruiz CD; Iglesias D; Sosa F; Sung L
Transpl Infect Dis; 2018 Aug; 20(4):e12913. PubMed ID: 29679436
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients.
Cesaro S; Tridello G; Castagnola E; Calore E; Carraro F; Mariotti I; Colombini A; Perruccio K; Decembrino N; Russo G; Maximova N; Baretta V; Caselli D
Eur J Haematol; 2017 Sep; 99(3):240-248. PubMed ID: 28556426
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
8. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
[TBL] [Abstract][Full Text] [Related]
9. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of invasive fungal infections in immunocompromised children; an Australian national 10-year review.
Bartlett AW; Cann MP; Yeoh DK; Bernard A; Ryan AL; Blyth CC; Kotecha RS; McMullan BJ; Moore AS; Haeusler GM; Clark JE
Pediatr Blood Cancer; 2019 Apr; 66(4):e27564. PubMed ID: 30511385
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic SCT in patients with a history of invasive fungal infection.
Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
[TBL] [Abstract][Full Text] [Related]
12. Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group.
Hazar V; Karasu GT; Uygun V; Öztürk G; Kiliç SÇ; Küpesiz A; Daloglu H; Aksoylar S; Atay D; Ince EÜ; Karakükçü M; Özbek N; Tayfun F; Kansoy S; Özyürek E; Akçay A; Gürsel O; Haskologlu S; Kaya Z; Yilmaz S; Tanyeli A; Yesilipek A
Med Mycol; 2019 Feb; 57(2):161-170. PubMed ID: 29608706
[TBL] [Abstract][Full Text] [Related]
13. The D-index is not correlated with invasive fungal infection during the early-post engraftment phase among allogeneic hematopoietic stem cell transplant recipients.
Abad CLR; Lahr B; O'Horo JC; Vijayvargiya P; Walker RC; Hogan WJ; Tande AJ
Int J Hematol; 2020 Feb; 111(2):293-302. PubMed ID: 31709502
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
[TBL] [Abstract][Full Text] [Related]
15. Secondary antifungal prophylaxis in pediatric hematopoietic stem cell transplants.
Azik FM; Tezer H; Ozkaya-Parlakay A; Aksu T; Bayram C; Fettah A; Tavil B; Tunç B
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e19-22. PubMed ID: 25522351
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients.
Liu F; Wu T; Wang JB; Cao XY; Yin YM; Zhao YL; Lu DP
Transpl Infect Dis; 2013 Jun; 15(3):243-50. PubMed ID: 23496156
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis.
Biyun L; Yahui H; Yuanfang L; Xifeng G; Dao W
Clin Microbiol Infect; 2024 May; 30(5):601-610. PubMed ID: 38280518
[TBL] [Abstract][Full Text] [Related]
19. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation].
Zhang Y; Liu C; Liu QF; Sun J; Fan ZP; Xu D; Jiang QL
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2814-7. PubMed ID: 20137659
[TBL] [Abstract][Full Text] [Related]
20. Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.
Simms-Waldrip T; Rosen G; Nielsen-Saines K; Ikeda A; Brown B; Moore T
Infect Dis (Lond); 2015 Apr; 47(4):218-24. PubMed ID: 25650728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
